Skip to main content

Table 2 Baseline clinical characteristics

From: Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia

Baseline clinic characteristics N = 33
n (%)
Disease diagnosis time in yearsa 2 (1–5,5)
SLE manifestation
 • Renal 27 (81,8)
 • Articular 19 (57,6)
 • Hematological 19 (57,6)
 • Mucocutaneous 18 (54,5)
 • Serositis 8 (24,2)
 • Central Nervous System 8 (24,2)
 • Pulmonary 4 (12,1)
Previous hospitalization 28 (84,8)
Previous hospitalization daysa 5 (1–15)
Previous ICU admission 4 (12,1)
Outpatient treatment
 • Steroids 28 (84,8)
 • Chloroquine 22 (66,6)
 • Rituximab 4 (12,1)
 • Azathioprine 4 (12,1)
 • Mycophenolate 4 (12,1)
 • Cyclophosphamide 2 (6,0)
 • Methotrexate 1 (3,0)
 • Leflunomide 1 (3,0)
 • Calcineurin inhibitors 1 (3,0)
  1. aMedian/Interquartile range (IQR)